Wisp is expanding its women’s telehealth platform into diagnostics, fertility, menopause, and longevity with newly appointed CEO Keira Krausz.
Wisp has served more than 2 million patients across the US, spanning a range of women’s health needs and lifestages. Known for its sexual and reproductive health treatments, including UTI and STI care, the platform has evolved into a 24/7 women’s healthcare hub over the past eight years.
To lead its next phase of growth, Wisp tapped longtime direct-to-consumer operator Krausz, former Chief Marketing Officer of Purple. The company recently expanded into weight management and longevity care with prescription peptides and is now rolling out additional offerings including preventive diagnostics, fertility care, menopause support, mitochondrial health, cognitive health, and skincare.
“Two million patients is proof that women are looking for a fundamentally different healthcare experience – one that takes them seriously, fits into their lives, and doesn’t make them jump through hoops to get the care they need,” said Krausz. “Wisp has already changed the way millions of women access sexual and reproductive care. Now, we have an opportunity to bring that same experience to more of women’s health and build a platform that can be there for them not just for one moment, but for decades.”
